the finance of immunogenicity
Published 11 years ago • 513 plays • Length 14:24Download video MP4
Download video MP3
Similar videos
-
13:02
propresent® - the antigen presentation assay
-
7:10
an integrated approach and strategies to mitigate immunogenicity risk
-
45:14
jeremy fry: tools and technologies for comprehensive immunogenicity risk management
-
31:11
jeremy fry: an integrated approach to managing immunogenicity risk and optimum protein design
-
5:22
pro5 mhc class i pentamers
-
4:42
imeta | bioprospecting of culturable marine biofilm bacteria for novel antimicrobial peptides
-
32:04
immunomodulators
-
7:37
immunogenicity -properties determining immunogenicity of a substance (fl-immuno/21)
-
56:55
jeremy fry: tools and technologies for immunogenicity risk management
-
29:40
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
5:59
evaluating immunogenicity risk of complex peptide products
-
53:26
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
50:21
xiaoying chen: a systems pharmacology approach to immunogenicity
-
36:09
susan kirshner fda: therapeutic proteins: routes of exposure and the risk of immunogenicity
-
59:40
manoj rajadhyaksha: building a value added proposition for immunogenicity risk management
-
41:31
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
35:21
tim hickling: applying in vitro immunogenicity assays to predict clinical immunogenicity
-
28:50
jeremy fry: an integrated approach to managing immunogenicity risk and drug immune modulation
-
5:27
prosentium™: the t cell immuno-epiproteome at your fingertips
-
51:29
andrea ferrante: in-silico prediction of immunogenicity: filling the gaps